Form 4 for MRNA Moderna
Accepted 2026-05-04 17:25:09 ET · period of report 2026-04-30 · accession 0001682852-26-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-04 17:25 | 2026-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +16.2K | 17.7K | +1,071% | — |
| DT | 2026-05-04 17:25 | 2026-05-01 | MRNA | Hussain Abbas | Dir | S - Sale+OE | $46.63 | -5,682 | 12.1K | -32% | -$265.0K |
| DT | 2026-05-04 17:25 | 2026-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | $0.00 | -16.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | M | A | 16,233 | — | 17,748 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-05-01 | S | D | 5,682 | $46.63 | 12,066 | D | — | — | (F2) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2025. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-04-30 | M | D | 16,233 | $0.00 | 0 | D | — · — to — | 16,233 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The shares subject to this restricted stock unit award vested in full on April 30, 2026. (F3) The shares subject to this restricted stock unit award vested in full on April 30, 2026. |